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Introduction
Microtubules (MTs) are key cytoskeletal components that play 
a variety of essential roles in virtually every eukaryotic cell. An 
emerging mechanism that could control and coordinate differ-
ent MT functions is the tubulin code, which is generated by dif-
ferential expression of tubulin genes (isotypes) and by tubulin 
posttranslational modifications (PTMs; Janke, 2014). A hotspot 
of tubulin PTMs is the axoneme, the core structure of cilia and 
flagella (Konno et al., 2012). Out of the many PTMs found on 
axonemal MTs, glycylation is particular, as it has so far almost 
exclusively been detected in motile cilia and flagella (Redeker 
et al., 1994; Rüdiger et al., 1995; Bré et al., 1996; Weber et al., 
1996; Xia et al., 2000). Functional studies in different model or-
ganisms strongly suggest that glycylation controls the stability 
of the axoneme in motile cilia (Rogowski et al., 2009; Wloga et 
al., 2009; Pathak et al., 2011; Bosch Grau et al., 2013).
In mammals, glycylation is catalyzed by the enzymes of 
the tubulin tyrosine ligase-like (TTLL) family. Two enzymes, 
TTLL3 and TTLL8, are initiating glycylases that link the first 
glycine residues to the modification sites on tubulin, whereas 
TTLL10 is thought to only elongate preformed glycine chains, 
giving rise to polyglycylation (Rogowski et al., 2009). Glycyla-
tion generated by TTLL3 and TTLL8 is essential for axonemal 
stability, as codepletion of the two enzymes leads to disassem-
bly of motile cilia in ependymal cells (Bosch Grau et al., 2013). 
In contrast, polyglycylation appears to be nonessential despite 
its evolutionary conservation (Bré et al., 1996), as in humans, 
the polyglycylase TTLL10 is inactive (Rogowski et al., 2009). 
In contrast to motile cilia, where glycylation has been reliably 
detected with the monoclonal antibody TAP952 (specific to 
monoglycylation; Bré et al., 1996, 1998), the same antibody 
failed to detect the modification in most primary cilia. Conse-
quently, glycylation was widely considered a PTM specific to 
motile cilia; however, the first indications exist that the modifi-
cation is present at least in some primary cilia (Davenport et al., 
2007). We recently demonstrated that depletion of glycylating 
enzymes TTLL3 and TTLL8 leads to a partial loss of primary 
cilia in cultured fibroblasts. In the colon, where TTLL3 is the 
sole glycylase expressed, the absence of this enzyme leads to 
a decrease in the number of primary cilia. Strikingly, primary 
cilia in fibroblasts and colon tissues were not labeled with 
TAP952, leaving open the question of the presence and role of 
glycylation in primary cilia (Rocha et al., 2014).
Here, we have raised and characterized new antibodies 
specific to glycylation, which, in contrast to TAP952, label pri-
mary cilia. Using these novel antibodies, we demonstrate that 
the glycylation of primary cilia is generated progressively after 
cilia assembly and accumulates with increasing ciliary length. 
It thus appears that glycylation might stabilize primary cilia, 
similar to its function in motile cilia. To demonstrate this, we 
depleted glycylating enzymes in cultured cells and showed a 
significant shortening of primary cilia. In contrast, overex-
pression of cilia-targeted TTLL3 leads to an increase in cili-
As essential components of the eukaryotic cytoskeleton, microtubules fulfill a variety of functions that can be temporally 
and spatially controlled by tubulin posttranslational modifications. Tubulin glycylation has so far been mostly found on 
motile cilia and flagella, where it is involved in the stabilization of the axoneme. In contrast, barely anything is known 
about the role of glycylation in primary cilia because of limitations in detecting this modification in these organelles. We 
thus developed novel glycylation-specific antibodies with which we detected glycylation in many primary cilia. Glycyla-
tion accumulates in primary cilia in a length-dependent manner, and depletion or overexpression of glycylating enzymes 
modulates the length of primary cilia in cultured cells. This strongly suggests that glycylation is essential for the homeo-
stasis of primary cilia, which has important implications for human disorders related to primary cilia dysfunctions, such 
as ciliopathies and certain types of cancer.
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Figure 1. Generation of a new glycylation-specific antibody. (A) Multiple sequence alignment of the protein sequences of C-terminal tails of different α- and 
β-tubulin isotypes from humans compared with different species. Known sites for glycylation (green), glutamylation (red), or both PTMs (purple) are indicated 
according to the published data: pcTuba, pcTubb (Redeker et al., 1994; Vinh et al., 1997); ttTuba, ttTubb (Redeker et al., 2005); hsTuba1 (Eddé et al., 
1990); hsTuba3, hsTubb4b (Plessmann and Weber, 1997); spTuba, spTubb (Mary et al., 1996; Multigner et al., 1996); tbTuba, tbTubb (Schneider et al., 
1997); hsTubb2 (Rüdiger et al., 1992); and hsTubb3 (Alexander et al., 1991). pc, Paramecium cauda; tt, Tetrahymena thermophila; hs, Homo sapiens; tb, 
Trypanosoma brucei; sp, Strongylocentrotus purpuratus. (B) Glycylated peptides were designed based on human β2-tubulin with glycylation (green) at E437 
(gly-pep1) or E435 (gly-pep2) and without glycylation for control (control-pep). The peptides contain a carboxy group at the branched secondary-chain 
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ary length. Together, our findings demonstrate that glycylation 
is a tubulin PTM important for the maintenance and length 
control of primary cilia.
Results and discussion
Generation and validation of novel 
antibodies to glycylation
So far, cell biology research on tubulin glycylation has relied 
on two monoclonal antibodies, TAP952 and AXO49, which 
were both generated using tubulin from the ciliate Parame-
cium tetraurelia as an antigen (Levilliers et al., 1995; Bré et al., 
1996). A detailed characterization of the epitopes recognized 
by these antibodies revealed that TAP952 specifically detects 
glycylation sites with one single glycine (monoglycylation; Bré 
et al., 1998), whereas AXO49 detects glycine chains of three 
or more glycine residues (polyglycylation). A more recently 
introduced polyclonal antibody, polyG (Xia et al., 2000), de-
tects glycine chains of four or more glycine residues (Tort et al., 
2014). All these antibodies reliably stain motile cilia in a wide 
variety of eukaryotes (Bré et al., 1996; Bosch Grau et al., 2013), 
demonstrating that they are primarily not species selective and 
that both mono- and polyglycylation coexist on axonemal MTs, 
with the exception of humans, in which polyglycylation is ab-
sent (Rogowski et al., 2009).
In stark contrast to the reliable detection of monoglyc-
ylation in virtually all types of motile cilia, TAP952 does not 
label primary cilia in most cultured cells. So far, only one 
study has reported TAP952 staining of cilia in neuronal tissues 
(Davenport et al., 2007), whereas cilia in other tissues were 
not stained with this antibody (Rocha et al., 2014). TAP952 
was raised against P. tetraurelia tubulin (Callen et al., 1994), 
where it specifically detects glycylated E437, E438, E439, 
E441, and in particular the combination of all these modifica-
tion sites on β-tubulin (Bré et al., 1998). We compared these 
sites with potential modification sites of various tubulin iso-
types across species by multiple sequence alignment of α- and 
β-tubulin tails. As glycylation and glutamylation can occur on 
similar modification sites, we have labeled all potential sites 
that have so far been described in the literature (Fig. 1 A). 
Our alignment shows that there is a range of known modifi-
cation sites with varying surrounding sequence motives, and 
not all these potential modification sites align with the previ-
ously mapped TAP952 sites (Bré et al., 1998). In particular, 
β2- Tubulin, one of the major β-tubulin isotypes expressed in 
mammals, shows a divergent amino acid sequence in the re-
gion that is prone to either glycylation or glutamylation (E435 
and E437) in different species analyzed so far (Fig. 1 A). It is 
thus possible that TAP952 does not detect all possible glycy-
lation sites on mammalian tubulin, which is why we decided 
to raise novel glycylation-specific antibodies.
We synthesized two glycylated peptides that mimic 
the C-terminal tail of β2-tubulin, gly-pep1 (monoglycylated 
at E437; Fig.  1  B and Fig. S1 B) and gly-pep2 (monoglyc-
ylated at E435; Fig.  1  B and Fig. S1 C). Antibodies raised 
against these peptides were tested for specificity by spot blot 
against all glycylated peptides, including biglycylated forms 
of gly-pep1 and gly-pep2 (Fig.  1  C and Fig. S1, D and E). 
Both anti–gly-pep1 and anti–gly-pep2 (named gly-pep1 and 
gly-pep2) were highly specific to their initial, monoglycylated 
antigens, but also to the respective biglycylated peptides (Fig. 
S1, D and E). The antibodies also cross-reacted with other 
monoglycylated peptides, but not with the unmodified pep-
tide (control-pep; Fig. 1 B and Fig. S1 A), underpinning their 
specificity to glycylation. Strikingly, TAP952 detected both 
peptides very weakly only after overnight incubation with un-
usually high antibody concentrations (Fig. 1 C).
To test the specificity of the novel antibodies for glycy-
lation, we analyzed extracts from HEK293 cells expressing 
YFP-tagged glycylases TTLL3 and TTLL8 (Rogowski et al., 
2009) and glutamylases TTLL4, TTLL5, TTLL6, and TTLL7 
(van Dijk et al., 2007) by immunoblot. Gly-pep1, gly-pep2, and 
TAP952 detected specific protein bands in cells overexpressing 
glycylases, but not glutamylases (Fig. 1 D). Glutamylation was 
verified with GT335 (purified mouse monoclonal antibody). 
Strikingly, the principal protein band glycylated by TTLL3 
corresponds to β-tubulin, whereas TTLL8 generates many 
glycylation- specific protein bands including α-tubulin, showing 
that our novel antibodies detect a range of glycylated proteins. 
The presence of nontubulin substrates of glycylation has been 
previously reported (Lalle et al., 2006; Xie et al., 2007; Ikegami 
et al., 2008; Rogowski et al., 2009), but most of these proteins 
have so far remained unidentified.
To test our new antibodies in immunofluorescence, we 
transfected U2OS cells with YFP-tagged TTLL3 and TTLL8 
and labeled for glycylated and total tubulin. Similar to TAP952, 
gly-pep1 selectively stained the MT cytoskeleton in YFP- 
positive cells, whereas untransfected cells remained completely 
unlabeled (Fig. 1 E). Gly-pep2, in contrast, generated a diffuse, 
nonspecific staining in immunofluorescence (not depicted). 
Thus, we chose to carry on with gly-pep1 antibody, which we 
purified using a column with immobilized gly-pep1 peptide as 
the affinity matrix (Fig. S1, F and G).
Glycylation of primary cilia
To determine to what extent the gly-pep1 antibody detects glyc-
ylation in primary and motile cilia, we used ependymal cell 
cultures (Spassky et al., 2005). Strikingly, gly-pep1 labeled 
both primary and multiple motile cilia at every stage of ependy-
mal development (Fig.  2, A and B). In contrast, TAP952 did 
not label short primary cilia and weakly labeled long primary 
cilia or immature multiple cilia, but it strongly stained mature 
motile cilia (Fig. 2 B) as described previously (Bosch Grau et 
glycine, but not at the C-terminal amino acid of the peptides, to focus antigenicity to the glycylation modification. An additional cysteine (C, yellow) was 
added for peptide coupling. (C) Spot blot analyses of gly-pep antibodies. 300 nmol of control, mono-, or biglycylated β2-tubulin C-terminal–tail peptides 
were spotted on nitrocellulose membrane and incubated with gly-pep1, gly-pep2, or TAP952. Testes extract from mice were used as a positive control for 
glycylation. (D) Immunoblot analyses of HEK293 cell lysates expressing YFP-tagged enzymes of the TTLL family (TTLL3, TTLL8: glycylases [Rogowski et al., 
2009]; TTLL4, TTLL5, TTLL6, and TTLL7: glutamylases; short versions of TTLL4 and TTLL7 were used; van Dijk et al., 2007). Blots were probed with gly-pep1, 
gly-pep2, or TAP952 (*, overnight incubation of TAP952) antibodies for glycylation, with GT335 for glutamylation and with anti-GFP antibody to visualize 
the expression of the YFP-tagged TTLLs. (E) The specific staining of glycylation antibodies to glycylated MTs was tested by immunofluorescence staining 
of U2OS cells transfected with YFP-tagged TTLL3 or TTLL8 glycylases. Fixed cells were stained with gly-pep1 or TAP952 (red) and for tubulin (12G10 or 
TAT-1; gray). Bars, 10 µm.
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Figure 2. Gly-pep1 antibody labels motile and primary cilia. (A and B) Radial glial cells isolated from 1-d-old WT mice were differentiated to ependymal 
multiciliated cells in vitro for different time periods, and glycylation was monitored with gly-pep1 (red) combined with ac-tubulin (green) to determine ciliary 
length (A), or with TAP952 (green; B). Whereas gly-pep1 specifically labels primary and motile cilia, TAP952 only labels fully developed multiple motile 
cilia at a later stage of differentiation. (C and D) RPE-1 cells (C) and IMCD3 cells (D) were serum starved for 3 d and stained with gly-pep1 (red) and 
ac-tubulin (green). None of the primary cilia in these two cell lines were gly-pep1 positive. (E) MDCK cells were serum starved for 3 or 7 d and stained 
with either gly-pep1 or TAP952 (red) together with ac-tubulin (green). Note that gly-pep1 but not TAP952 specifically labels primary cilia. (F) Immunoblot 
analysis of tubulin glycylation in MDCK cells. Extracts of unstarved, 10-d–serum-starved, and starved and deciliated MDCK cells were analyzed together 
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al., 2013). We next analyzed the cell lines MDCK (dog kid-
ney cells), IMCD3 (mouse kidney cells), and RPE-1 (human 
retinal epithelial cells), which grow primary cilia after serum 
starvation (Plotnikova et al., 2009). IMCD3 and RPE-1 cells 
grew relatively short primary cilia, which were not detected 
with gly-pep1 (Fig.  2, C and D). In contrast, MDCK cells 
grew very long primary cilia, which were often stained with 
gly-pep1, but never with TAP952 (Fig.  2 E). Thus, the novel 
gly-pep1 antibody revealed the presence of posttranslational 
glycylation in primary cilia.
To investigate whether the glycylation signal in the pri-
mary cilia of MDCK cells originates from glycylated MTs, 
we deciliated 10-d-starved MDCK cells with (NH4)2SO4 for 
3 h (Overgaard et al., 2009). We collected the detached cilia 
(and floating cells) from the cell culture medium by centrifu-
gation and compared this fraction with extracts of unstarved, 
starved, and deciliated MDCK cells by immunoblot. Starved 
HeLa cells, which do not grow cilia, were included as a neg-
ative control. All fractions were analyzed with gly-pep1 in 
immunoblots, which detected a specific protein band at ∼50 
kD, the size of β-tubulin. Although this band was not detected 
in HeLa cells, it was already present in the unstarved MDCK 
cells and increased in intensity upon induction of ciliogenesis. 
When MDCK cells were deciliated, the signal decreased and 
was recovered in the ciliary fraction (Fig. 2 F). This indicates 
that most of the glycylated tubulin is found in the primary 
cilia of MDCK cells. As no other gly-pep1–positive protein 
was detected, it is likely that the gly-pep1 labeling of the 
primary cilia (Fig. 2 E) originated exclusively from the glyc-
ylation of axonemal MTs.
The glycylation signal in primary cilia was unevenly dis-
tributed: it was most prominent at the proximal part of the cilia, 
as visualized by costaining of the basal body (centrin; Fig. 2 G). 
However, it was not confined to the well-defined ciliary tran-
sition zone (Czarnecki and Shah, 2012), which we visualized 
by expressing the transition zone–specific protein inversin (3× 
FLAG-INVS; Czarnecki et al., 2015) in MDCK cells (Fig. 2 H).
Glycylation of primary cilia accumulates on 
cilia with increasing length
To determine the kinetics of glycylation in primary cilia, 
MDCK cells were starved for 1 or 3 d, and their length was 
determined by measuring the acetylated-tubulin (ac-tubulin) 
signals (Fig. 3 A). At both time points, a range of different cilia 
lengths was present, indicating that the ciliation process was 
asynchronous (Fig. 3 B). However, the percentage of cilia with 
a clear gly-pep1 signal was consistently low for short cilia and 
increased with the length of cilia (Fig. 3 C). Although the same 
trend was found after 1 and 3 d of starvation, slightly higher 
numbers of cilia were glycylation positive after 3 d. It thus ap-
pears that glycylation is mostly length dependent; however, we 
could not exclude the possibility that shorter cilia are not glyc-
ylated because the machinery necessary for glycylation is not 
fully available at the beginning of ciliation.
To test this possibility, we repeated our analyses with cells 
that had already been ciliated and in which a second round of 
ciliogenesis was reinduced after chemical deciliation. MDCK 
cells were allowed to ciliate for 2 d, treated with 30  mM 
(NH4)2SO4 for 3 h for complete deciliation, and subsequently 
allowed to reciliate (Fig. 3 D). 1 d after deciliation and restarva-
tion, MDCK cells had grown predominantly short primary cilia, 
whereas after 3 d, most cilia had grown longer (Fig. 3, D and E). 
Strikingly, we found a very similar length–glycylation correla-
tion as in the nonsynchronously ciliated cells: shorter cilia were 
less glycylated than longer cilia, and a slight accumulation of 
glycylation in shorter cilia was observed after 3 d of starvation 
(Fig. 3, compare F with C). Together, these results demonstrate 
that glycylation, as detectable with gly-pep1 antibody, accumu-
lates in primary cilia in a predominantly length-dependent man-
ner and might play a particularly important role for longer cilia.
This also suggests that glycylation was not detected 
in cilia of IMCD3 or RPE-1 cells (Fig.  2, C and D) because 
these cells grew only short cilia. To test this hypothesis, we let 
IMCD3 cells ciliate for 2 d and then treated them with 50 mM 
LiCl to increase ciliary length (Miyoshi et al., 2009, 2011; 
Thompson et al., 2016). Ciliary length was determined after 12, 
24, and 36 h of LiCl incubation (Fig. 4 A) and compared with 
untreated controls. Although in controls, most cilia remained 
shorter than 3 µm, the presence of LiCl led to a progressive 
elongation of cilia, with some cilia growing even longer than 
6 µm (Fig. 4 B). Strikingly, at 36 h after the addition of LiCl, 
cilia again became shorter, an effect that had previously been 
reported (Miyoshi et al., 2009).
IMCD3 cilia were overall less strongly labeled with gly-
pep1 as compared with MDCK cilia (compare Fig. 3, A and D; 
and Fig. 4 A, red), but the number of gly-pep1–positive cilia 
increased with ciliary length in both LiCl-treated and control 
IMCD3 cells (Fig. 4 C). Strikingly, a much higher percentage 
of cilia was stained with gly-pep1 in all length categories in 
cells treated for 36 h with LiCl. It is possible that this reflects 
an accumulation of glycylation in the LiCl-induced elongated 
cilia, which reached their maximum length at 24 h and began 
to shrink at 36  h (Fig.  4  D) without losing their glycylation 
(Fig. 4 C). Thus, chemically induced elongation of primary cilia 
can induce glycylation in previously nonglycylated, short cilia.
Glycylation controls the length of 
primary cilia
The correlation between the length of primary cilia and the 
presence of glycylation detected with the antibody gly-pep1 
suggests that glycylation could be implicated in the control of 
ciliary length, perhaps by stabilizing the axonemes as previously 
proposed for motile cilia (Wloga et al., 2009; Bosch Grau et al., 
2013), sperm flagella (Rogowski et al., 2009), and connecting 
cilia of photoreceptors (Bosch Grau et al., 2017). To test this 
hypothesis, we aimed to deplete glycylation from MDCK cells. 
MDCK cells express detectable, though low, amounts of TTLL3 
(Fig. S2 A), whereas no expression of TTLL8 could be detected 
with the cilia fraction from the deciliated cells using gly-pep1 antibody and 12G10. Starved HeLa cells were used as a negative control. (G) Serum-starved 
MDCK cells were stained with gly-pep1 (red), 6–11-B1 (ac-tubulin; green), and 20H5 (pan-centrin; cyan). The gly-pep1 staining was localized in the vicinity 
of the centrin-stained basal body, indicating that glycylation accumulates at the proximal part of primary cilia. Note that the centrioles are not stained with 
gly-pep1, indicating that only axonemal MTs undergo glycylation. (H) MDCK cells transduced with 3× FLAG-INVS were colabeled with gly-pep1 (red), 
6–11-B1 (ac-tubulin; green), and anti-FLAG antibody (cyan). Note that irrespective of the length of the cilia (ac-tubulin) or of the absence or presence of 
glycylation (gly-pep1), the size of the inversin segment was identical. Bars, 10 µm; magnified images, 2 µm.
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(not depicted). We thus knocked down TTLL3 expression in 
MDCK cells using lentiviral shRNA constructs. All three shR-
NAs led to a reduction of TTLL3 expression (Fig. S2 A), and 
cilia were remarkably shorter in TTLL3-shRNA–treated cells 
as compared with the scramble control, with TTLL3_994 hav-
ing the strongest impact on ciliary length (Fig. 5, A and B; and 
Fig. S2, B, C, and E). In both TTLL3-shRNA– and scramble- 
shRNA–treated cells, the percentage of glycylated cilia was 
consistently higher when cilia were longer (Fig. 5 C and Fig. 
S2 D). However, for each length category, the percentage of 
glycylated cilia was lower in TTLL3-shRNA–treated cells as 
compared with scramble-shRNA (Fig. 5 C and Fig. S2 D), con-
Figure 3. Glycylation in primary cilia of MDCK cells is length dependent. (A) MDCK cells were serum starved for 1 or 3 d and analyzed by immunostain-
ing with ac-tubulin (green) and gly-pep1 (red) antibodies. (B) Quantification of ciliary length (length of ac-tubulin signal in A) from MDCK cells starved for 
1 or 3 d. The graph represents the percentage of cilia for each length category. Each bar represents the mean of three independent experiments (±SD). 
(C) Graphic representation of the percentage of gly-pep1–positive cilia for each length category. Each bar represents the mean of three independent ex-
periments (±SD), using the same images that were quantified in B. (D) Immunofluorescence analysis of serum-starved MDCK cells after a cycle of ciliation–
deciliation. After deciliation, cells were restarved for 1 or 3 d and stained for ac-tubulin (green) and glycylation (red). Note that upon deciliation, all cells 
lost their cilia. Bars, 10 µm. (E) Quantification of ciliary length in deciliated and reciliated cells, which were analyzed as described in B. (F) Percentage of 
glycylated (gly-pep1) cilia in deciliated and reciliated cells analyzed as described in C.
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Figure 4. Elongation of short primary cilia induces their glycylation. (A) Confluent IMCD3 cells were serum starved in the absence (control) and presence 
of 50 mM LiCl for 12, 24, and 36 h and stained for ac-tubulin (green) and glycylation (gly-pep1; red). Bars, 10 µm. (B) Quantification of ciliary length 
for A. The graphs represent the percentage of cilia for each length category. Each bar represents the mean of three independent experiments (±SD). 
(C) Percentage of gly-pep1–positive cilia in the different length categories, represented as in B. (D) Ciliary length measurements from three independent 
experiments for each experimental condition shown in A are represented as a scatter plot with a line indicating the median (value indicated) and whiskers 
at interquartile ranges (25th and 75th percentiles). P-values were calculated by one-way ANO VA. Individual experiments are shown in Fig. S3 A. For the 
number of individual measurements per data point, see Table S1 (n > 450).
JCB • Volume 216 • NumBer 9 • 20172708
Figure 5. Glycylation regulates ciliary length. (A) MDCK cells were transduced with scrambled or TTLL3-specific shRNA constructs (Fig. S2 A) and serum 
starved for 3 d. Cilia were stained with ac-tubulin (green) and glycylation with gly-pep1 (red). Note the strong decrease of ciliary length in cells treated with 
shRNA TTLL3_994. Bars, 10 µm. (B) Quantification of the ciliary length for A. The graphs represent the percentage of cilia for each length category. Each 
bar represents the mean of three independent experiments (±SD). (C) Percentage of gly-pep1–positive cilia was determined for each of the different length 
groups and plotted as the mean value of three independent experiments (±SD). (D) Ciliary length measurements from three independent experiments for 
each experimental condition shown in A are represented as a scatter plot with a line indicating the median (value indicated) and whiskers at interquartile 
ranges (25th and 75th percentiles). P-values were calculated by one-way ANO VA. Individual experiments are shown in Fig. S3 B. For the number of indi-
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firming that depletion of TTLL3 leads to a decrease of glycy-
lation in cilia. This also suggests that the cells that still have 
longer cilia in TTLL3-shRNA–treated samples might have been 
less efficiently depleted of TTLL3 than the majority of the cells. 
Together, these experiments demonstrate that the depletion of 
glycylation in MDCK cells leads to a significant decrease of 
ciliary length (Fig. 5 D and Fig. S2 E). In contrast to our previ-
ous observations in connecting cilia of photoreceptors, in which 
the absence of TTLL3 led to a gradual increase in glutamylation 
and photoreceptor degeneration (Bosch Grau et al., 2017), the 
shortening of primary cilia after depletion of glycylation was 
not accompanied by a detectable up-regulation of glutamylation 
(GT335; Fig. S2 F). This indicates that the reduction in ciliary 
length is most likely induced by a mechanism that is directly 
controlled by glycylation levels of the axonemal MTs.
Finally, we asked whether a forced increase of glycyla-
tion in the primary cilia could induce ciliary elongation. Over-
expression of glycylation in cultured cells leads to a massive 
glycylation of the entire MT cytoskeleton and was therefore not 
appropriate to test the role of glycylation specifically in cilia. 
We thus generated a lentiviral vector in which we combined a 
promoter with very low activity (Nager et al., 2017), a ciliary 
localization signal (CLS) derived from Nephrocystin-3 (Mick 
et al., 2015), and the GFP-tagged TTLL3 protein or its ATPase- 
dead mutant. Cells transduced with these constructs and serum 
starved for 3 d showed a very weak but specific GFP signal in 
the primary cilia. In the case of TTLL3, this lead to a massive 
accumulation of glycylation (gly-pep1 signal) in the primary 
cilia, whereas cytosolic MTs were only faintly glycylated, indi-
cating that our approach of targeting glycylation into cilia had 
been successful (Fig.  5  E). Expression of CLS-GFP-TTLL3 
led to an ∼2.5-fold increase of ciliary length as compared with 
control (Fig. 5, F and G). However, expression of the CLS-
GFP-TTLL3–dead constructs also increased ciliary length, 
but to a lesser extent (∼1.5-fold over control; Fig.  5, F and 
G), which is most likely related to the cilia-stabilizing effect 
of the CLS. The glycylation-related increase of ciliary length 
(Fig. 5, F and G) demonstrates that this tubulin modification is 
involved in the control of ciliary length, but it is not sufficient 
to increase the ciliary length in IMCD3 cells at a scale seen 
in MDCK cells. Thus, additional mechanisms, which could be 
directly regulated by the glycylation status of the ciliary axon-
emes but are absent in IMCD3 cells, might be involved in length 
scaling of primary cilia.
Conclusions
Primary cilia are key organelles with crucial roles in signaling 
pathways (Lancaster et al., 2011; Basten and Giles, 2013; Del-
ling et al., 2013; Fry et al., 2014; Malicki and Johnson, 2017), 
and their dysfunction can lead to ciliopathies (Tobin and Beales, 
2009; Hildebrandt et al., 2011; Waters and Beales, 2011; Huber 
and Cormier-Daire, 2012) or cancer (Michaud and Yoder, 2006; 
Wong et al., 2009; Han and Alvarez-Buylla, 2010; Basten and 
Giles, 2013). Despite our initial observations that posttrans-
lational glycylation is important for primary cilia and tissue 
proliferation (Rocha et al., 2014), this modification was so far 
almost exclusively detected in motile cilia (Rogowski et al., 
2009; Wloga et al., 2009; Pathak et al., 2011; Bosch Grau et 
al., 2013). Here, we developed a novel antibody, which allowed 
us to demonstrate the presence of glycylation in primary cilia 
and also to determine its role in controlling the length of these 
organelles. Our findings are of key importance for virtually all 
functions related to cilia and have repercussions for the under-
standing of the molecular mechanisms of primary cilia func-
tions and their role in a wide range of cilia-related disorders.
Materials and methods
Peptide synthesis and antibody production
The sequences for the C-terminal tail peptides of β2-tubulin were 
designed with glycylation on the most frequently modified amino 
acid residues on β-tubulins of different species (Fig.  1  A). Peptides 
were synthesized using a standard peptide synthesis protocol with 
a mono- or biglycylated glutamate building block for the modified 
sites (Fig. 1 B) and were purified by HPLC (Peptide Specialty Lab-
oratory). Peptides were then coupled to keyhole limpet hemocyanin. 
Antibodies were raised in rabbits (Pettingill Technology). The TAP952 
antibody was produced from hybridoma cell lines and purified on a 
protein G affinity column (17-0405-01; GE Healthcare) with the help 
of A. Aubusson-Fleury (Institut de Biologie Intégrative de la Cellule, 
Gif-sur-Yvette, France).
Cell culture and transfection
HEK293 (CRL-1573; ATCC), HeLa (CCL-2; ATCC), and U2OS (HTB-96; 
ATCC) cells were cultured under standard conditions in DMEM/F12 
culture media (Thermo Fisher Scientific) containing 10% FBS (Sigma 
Aldrich). Transfection of expression plasmids was performed using 
jetPEI (PolyPlus) transfection reagent according to the manufacturer’s 
instructions. Cells were analyzed 20 h after transfection.
For primary ependymal cell culture, we used the published 
protocol for isolation, culturing, and differentiation (Delgehyr et al., 
2015). In brief, cells from the subventricular zone of the brains of new-
born pups of WT C57B6/J mice were isolated, dissociated, washed, 
and plated at high density in DMEM/F12 containing 10% FBS in a 25-
cm2 flask precoated with poly-l-lysine (P4832; Sigma Aldrich). When 
cells reached confluency, the astroglial monolayer was replated onto 
precoated 12-mm glass coverslips in 24-well plates at a density of 104 
cells/µl and maintained in serum-free medium to enable differentiation. 
Cells were fixed at the different time points, and cells representative of 
different developmental stages were imaged.
Spot blot and immunoblot analyses
To test the specificity of gly-pep1 and gly-pep2 antibodies, a spot blot 
analysis modified from Bré et al. (1996) was used. 300 nmol of each 
synthetic β-tubulin peptide (control, gly-pep1, bi–gly-pep1, gly-pep2, 
and bi–gly-pep2) was spotted on preactivated nitrocellulose membrane 
strips and dried for 5 min at 50°C.
vidual measurements per data point, see Table S1 (n > 1,000). (E) IMCD3 cells were transduced with active or mutant TTLL3 fused to GFP and a CLS and 
serum starved for 3 d. Cilia were stained with ac-tubulin (green) and glycylation with gly-pep1 (red). GFP is depicted in gray. Note the increase in length 
of cilia positive for gly-pep1 in cells transduced with active TTLL3. (F) Quantification of the ciliary length in control cells and cells transduced with active 
or mutant TTLL3 as described in D. In transduced cells, only GFP-positive cilia were considered for analyses. (G) Ciliary length measurements from three 
independent experiments for each experimental condition shown in E are represented as a scatter plot with a line indicating the median (value indicated) 
and whiskers at interquartile ranges (25th and 75th percentiles). P-values were calculated by one-way ANO VA. Individual experiments are shown in Fig. 
S3 C. For the number of individual measurements per data point, see Table S1 (n > 1,100).
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For immunoblot analyses of cell extracts, HEK293 cells were 
plated in 6-well plates (7 × 105 cells/well) and transfected with ex-
pression plasmids for YFP-fusion proteins of different TTLL pro-
teins (van Dijk et al., 2007; Rogowski et al., 2009) using jetPEI. 
Cells were harvested 20 h after transfection, directly lysed in SDS 
sample buffer, and run on 10% SDS-PAGE gels. A specific proto-
col was used to separate α- and β-tubulin (Magiera and Janke, 2013). 
In brief, specific SDS-PAGE gels were prepared at 375  mM Tris-
HCl, pH 9.0, 0.1% SDS (L5750; Sigma Aldrich), and 10% acryl-
amide (40% acrylamide solution; 161-0140; Bio-Rad) supplemented 
with 0.54% bis-acrylamide (wt/vol) powder (161-0210; Bio-Rad). 
Proteins were transferred to nitrocellulose membranes with Trans-
Blot Turbo using transfer packs (1704159; Bio-Rad) and subjected 
to immunoblot analysis.
Membranes from spot blots and immunoblots were blocked for 
1 h with 50 mM TBS with 0.1% Tween 20 (TBS-T) containing 5% 
nonfat milk and then incubated for 2 h at room temperature (spot blot/
immunoblot) with anti–gly-pep1 (purified, 1 mg/ml: 1:2,500/1:5,000; 
AG-25B-0034; Adipogen Life Sciences), anti–gly-pep2 (rabbit serum, 
1:500/1:1,500), and 12G10 (immunoblot, 1:500; antibody developed by 
J. Frankel and M. Nelson and obtained from the Developmental Studies 
Hybridoma Bank developed under the auspices of the National Institute 
of Child Health and Human Development and maintained by the Uni-
versity of Iowa). TAP952 (purified mouse monoclonal antibody, 1 mg/
ml: 1:100/1:400) was incubated overnight at 4°C. For glutamylation, 
immunoblots were incubated with GT335 (purified mouse monoclo-
nal antibody, 1:5,000; AG-20B-0020-C100; Adipogen Life Sciences), 
and for detecting the expression of YFP-tagged proteins, with poly-
clonal rabbit anti-GFP antibody (1:5,000; TP401; Torrey Pines Bio-
labs). Antibodies were diluted in TBS-T containing 2.5% nonfat milk. 
Membranes were washed four times with TBS-T and then incubated 
for 1.5 h with goat anti–rabbit (31460; Thermo Fisher Scientific) or 
anti–mouse (31430; Thermo Fisher Scientific) secondary antibodies 
conjugated to HRP diluted to 1:10,000 in TBS-T. After washing five 
times in TBS-T, antibody labeling was revealed using ECL Western 
blotting detection reagent (GE Healthcare).
Ciliogenesis
RPE-1 (CRL-4000; ATCC), MDCK (CCL-34; ATCC), and IMCD3 
(CRL-2123; ATCC) cells were plated on 12-mm glass coverslips in a 
24-well plate and cultured to confluency in DMEM/F12 (1:1; Thermo 
Fisher Scientific) containing 10% FBS. The cells were then washed 
twice with PBS and cultured in serum-free DMEM/F12 for different 
time intervals to induce ciliogenesis.
IMCD3 cells for LiCl treatment (Fig. 4) were plated on 12-mm 
glass coverslips, grown to confluence, and serum starved for 2 d. The 
cells were then cultured in starvation medium containing 50 mM LiCl 
(Thompson et al., 2016) for different time intervals (12, 24, and 36 h). 
A series of control experiments was performed by omitting LiCl.
Deciliation and rescue of ciliogenesis
Deciliation and reciliation experiments were performed as described 
previously (Overgaard et al., 2009). For Fig. 3 (D and F), MDCK cells 
were plated on 12-mm glass coverslips and grown to confluence and 
then cultured in serum-free medium for 2 d to enable ciliogenesis. After 
ciliation, the cells were washed and incubated in complete medium 
with 30 mM (NH4)2SO4 for 3 h for deciliation. To rescue the cells and 
enable reciliation, the cells were washed twice with PBS and cultured 
in serum-free medium for 1 or 3 d.
For the immunoblot analysis of ciliary versus cellular fractions 
(Fig. 2 F), MDCK cells were starved for 10 d and then deciliated for 
3 h. The cell culture medium was harvested and subjected to repeated 
cycles of centrifugation at 2,000 g for 30 min at room temperature. The 
pellets were resuspended in lysis buffer (20 mM sodium phosphate, pH 
7.2, containing 150 mM NaCl, 1 mM EDTA, 10% [vol/vol] glycerol, 
1% Triton X-100, and protease inhibitor cocktail). 40 µg of total protein 
was analyzed by SDS-PAGE and immunoblot with purified gly-pep1 
(1:5,000) and 12G10 (1:1,000).
Cell fixation and immunofluorescence
Cells plated on 12-mm glass coverslips in 24-well plates were 
fixed with a protocol to preserve the cytoskeleton (Bell and Safie-
jko-Mroczka, 1995). In brief, the cellular proteins were cross-linked 
using the homobifunctional cross-linker dithiobis(succinimidyl pro-
pionate) (22585; Thermo Fisher Scientific) in MT-stabilizing buffer 
(MTSB) after permeabilization with 0.5% Triton X-100 in MTSB. The 
cells were then fixed with 4% paraformaldehyde in MTSB and trans-
ferred to PBS. For the experiments shown in Fig. 1 E, cells were first 
fixed and then permeabilized.
Primary ependymal cells and starved MDCK cells used for 
staining with anti-centrin antibody were permeabilized with 0.1% Tri-
ton X-100 in BRB80 (80 mM Pipes/KOH, pH 6.8, 5 mM EGTA, and 
5 mM MgCl2) for 90 s and then fixed in ice-cold methanol for 10 min 
at −20°C and transferred to PBS. Cells were blocked with PBS con-
taining 10% FBS for 1 h at room temperature (Delgehyr et al., 2015).
Primary antibodies were diluted in PBS containing 3% BSA 
and 0.1% Triton X-100 for 2 h at room temperature. We used pu-
rified gly-pep1 (1:5,000), TAP952 (1:1,000), mouse anti-acetylated 
α-tubulin (1:5,000; TEU318; AG-20B-0068-C100; Adipogen Life 
Sciences), mouse anti-Arl13b (1:750; N295B/66; NeuroMab), mouse 
anti–α-tubulin 12G10 (1:1,000) or TAT-1 (1:1,000; 00020911; Pub-
lic Health England), mouse anti-centrin (1:800; 04-1624, Sigma 
Aldrich), mouse anti-FLAG (1:1,000; F1804; Sigma Aldrich), and 
GT335 (1:5,000). For acetylated α-tubulin staining in the ependymal 
cells, 6–11-B1 (1:1,000; mouse monoclonal; MABT868; Sigma Al-
drich) was used. Secondary antibodies were diluted in the same buffer 
as the primary antibody and incubated for 1 h at room temperature. 
We used goat anti–rabbit Alexa Fluor 568 (1:1,000; A11036), goat 
anti–mouse IgG1 Alexa Fluor 488 (1:1,000; A21121), goat anti–
mouse IgG2a (1:1,000; A21235), or IgG2b Alexa Fluor 647 (1:1,000; 
A21242; Thermo Fisher Scientific). Nuclei were visualized by stain-
ing for 5 min with DAPI (0.02 µg/ml; D3571; Thermo Fisher Scien-
tific). Coverslips were mounted using ProLong gold antifade medium 
(P36930; Thermo Fisher Scientific).
TTLL3 knockdown 
Lentiviral particles of vectors encoding GFP or RFP together with 
shRNA under the control of the H1 promoter (shRNA scramble, 
TTLL3_478, TTLL3_556, or TTLL3_994) were generated by trans-
fecting them into X-Lenti 293T (632180; Clontech) cells together with 
viral packaging plasmids (psPAX2 and VSV-G) using Trans-IT-293 
transfection reagent (MIR 2705; Mirus Bio LLC). 16 h after transfec-
tion, the culture medium was replaced by Opti-MEM medium (Thermo 
Fisher Scientific) for a period of 30 h, allowing virus production. The 
virus-containing medium was collected, filtered, and stored at −80°C 
(Lahaye et al., 2013). Virus-containing cell culture media were cali-
brated for 90–100% transduction efficiency by directly adding different 
volumes of the media to MDCK cell cultures. The optimal volume for 
each virus was then used for further experiments.
MDCK cells grown to 50% confluence in complete DMEM/F12 
medium were cultured with lentivirus-containing medium for 2 d. Cells 
were washed extensively with PBS and cultured for an additional 3 d in 
serum-free medium to enable ciliogenesis. Cells were either harvested 
for RNA isolation or fixed as described earlier for immunofluorescence.
Tubulin glycylation controls primary cilia length • Gadadhar et al. 2711
Target sequences of shRNA were scramble, 5′-TGC GCT ACG 
ATC GAC GATG-3′; TTLL3_478, 5′-GAG AGA GCT GTC AAG CAG 
AAG-3′; TTLL3_556, 5′-GGC TGG GTG GAG AAG AAG ATG-3′; or 
TTLL3_994, 5′-GCC TTC ATA GAG GAC TTC TGG-3′.
Ciliary targeting with lentivirus expression vectors
Lentiviral constructs of codon-optimized full-length TTLL3 and the 
ATPase-dead version of TTLL3 were cloned into a lentiviral vector 
backbone, preceded by a low-activity EF1-α promoter with a mutated 
TATA box (Nager et al., 2017), the N-terminal region of Nephrocys-
tin-3, which acts as the CLS (Mick et al., 2015), and GFP. Plasmids 
used for subcloning were provided by D. Mick and M. Nachury (Stan-
ford University, Stanford, CA) and N.  Manel (Institut Curie, Paris, 
France). The lentiviral construct for the expression of flag-tagged in-
versin (pCDH-EF1-3× FLAG-INVS; Czarnecki et al., 2015) was a gift 
from J. Shah and P. Czarnecki (Harvard Medical School, Boston, MA). 
Lentiviral particles were produced as described above, and IMCD3 or 
MDCK cells were transduced with viruses containing the herein de-
scribed constructs, grown for 48 h in complete medium, washed, and 
serum starved for 3 d. Cells were then fixed as described for immu-
nofluorescence analyses.
Microscopy
All microscopy images apart from Fig. 1 E were acquired using a 
Structured Illumination microscope (Optigrid; Leica Systems) with a 
63× (NA 1.40) oil immersion objective at room temperature. Images 
were acquired using the ORCA-Flash4.0 camera (Hamamatsu) and 
MM AF imaging software (Leica Systems). For image analysis, the 
images were processed using ImageJ (National Institutes of Health). 
Images in Fig. 1 E were acquired with a spinning-disk inverted con-
focal laser microscope (Ti-E; Nikon) using a 60× oil immersion ob-
jective (NA 1.40) at room temperature. Images were acquired using 
the ORCA- Flash4.0 camera and MM AF imaging software. Multiple 
Z stacks were acquired, and a maximum intensity projection was pre-
pared using ImageJ v1.51a to generate the final image.
Quantification of cilia and statistics
Images with glycylation and cilia staining were processed in ImageJ 
v1.51a. Only the intensity of single-color channels was adjusted in 
a linear manner for better representation in the figures using ImageJ 
and Photoshop (Adobe), and no additional image treatments were 
performed. The length of the cilia was determined by measuring 
the acetylated α-tubulin signals using ImageJ. The percentage of 
gly-pep1–positive cilia was determined relative to the number of all 
(ac-tubulin positive) cilia.
For each experimental condition, experiments were performed in 
triplicates. For ciliation experiments with MDCK cells (Fig. 3), ∼500–
1,000 cilia were counted per experiment. For LiCl treatment of IMCD3 
cells (Fig. 4), ∼250 cilia were counted per experiment (Fig. S3 A). For 
ciliary length after TTLL3 knockdown in MDCK cells (Fig. 5, A–D; 
and Fig. S2), as well as TTLL3 overexpression in IMCD3 cells (Fig. 5, 
E–G), ∼350–450 cilia were counted per condition (Fig. S3, B and C). 
For IMCD3 cells overexpressing TTLL3, only GFP-positive cilia were 
counted. For each condition, ∼350–400 cilia were counted.
Mean values of individual experiments were plotted in bar graphs 
with ±SD between the individual sets. Numerical values for each of the 
quantifications are reported in Table S1.
For statistical analyses of ciliary length, we combined the three 
experimental replicates and represented all data as scatter plots with a 
line indicating the median and whiskers at interquartile ranges (25th 
and 75th percentiles; Fig. 4 D and Fig 5, D and G). P-values were cal-
culated by one-way ANO VA corrected for multiple comparisons using 
the Tukey statistical hypothesis test using Prism version 7 (GraphPad). 
Scatter plots for each of the individual experiments are represented in 
Fig. S3 to demonstrate the reproducibility of the experiments.
Online supplemental material
Fig. S1 describes the validation of the newly synthesized glycylated 
peptides and the purity of the gly-pep1 antibody. Fig. S2 shows com-
plementary results for the TTLL3 knockdown analyses described in 
Fig. 5. Fig. S3 represents the graphs of individual quantification exper-
iments, of which the collective graphs are shown in Fig. 4 D and Fig. 5 
(D and G). Table S1 provides the source data for all quantification ex-
periments shown in the manuscript.
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